140 related articles for article (PubMed ID: 35720317)
1. Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response.
Chen R; Zhang H; Wu W; Li S; Wang Z; Dai Z; Liu Z; Zhang J; Luo P; Xia Z; Cheng Q
Front Immunol; 2022; 13():931433. PubMed ID: 35720317
[TBL] [Abstract][Full Text] [Related]
2. Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response.
Chen R; Zhang H; Wu W; Li S; Wang Z; Dai Z; Liu Z; Zhang J; Luo P; Xia Z; Cheng Q
Front Immunol; 2022; 13():833792. PubMed ID: 35418980
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
Guo Y; Cen K; Chen Q; Dai Y; Mai Y; Hong K
Front Immunol; 2023; 14():1229541. PubMed ID: 37342331
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Coagulation Factor X Regulated by CASC2c Recruited Macrophages and Induced M2 Polarization in Glioblastoma Multiforme.
Zhang Y; Feng J; Fu H; Liu C; Yu Z; Sun Y; She X; Li P; Zhao C; Liu Y; Liu T; Liu Q; Liu Q; Li G; Wu M
Front Immunol; 2020; 11():934. PubMed ID: 32547542
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy.
Shafqat A; Omer MH; Ahmed EN; Mushtaq A; Ijaz E; Ahmed Z; Alkattan K; Yaqinuddin A
Front Immunol; 2023; 14():1252998. PubMed ID: 37520538
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Innate Immune Cells in the Esophageal Tumor Microenvironment.
Cui K; Hu S; Mei X; Cheng M
Front Immunol; 2021; 12():708705. PubMed ID: 34122459
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model.
Lee SWL; Adriani G; Ceccarello E; Pavesi A; Tan AT; Bertoletti A; Kamm RD; Wong SC
Front Immunol; 2018; 9():1719. PubMed ID: 30083166
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Tumor-Associated Macrophages in Tumor Immunity.
Pan Y; Yu Y; Wang X; Zhang T
Front Immunol; 2021; 12():775758. PubMed ID: 34956205
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages.
Orecchioni M; Ghosheh Y; Pramod AB; Ley K
Front Immunol; 2020; 11():234. PubMed ID: 32161587
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Efficient Capsid Antigen Presentation From Adeno-Associated Virus Empty Virions
Pei X; Earley LF; He Y; Chen X; Hall NE; Samulski RJ; Li C
Front Immunol; 2019; 10():3076. PubMed ID: 32117195
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications.
Mirzaei HR; Rodriguez A; Shepphird J; Brown CE; Badie B
Front Immunol; 2019; 10():780. PubMed ID: 31049049
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines.
Pazos-Castro D; Margain C; Gonzalez-Klein Z; Amores-Borge M; Yuste-Calvo C; Garrido-Arandia M; Zurita L; Esteban V; Tome-Amat J; Diaz-Perales A; Ponz F
Front Immunol; 2023; 14():1133046. PubMed ID: 36742331
[TBL] [Abstract][Full Text] [Related]
13. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
Front Immunol; 2021; 12():691811. PubMed ID: 34489938
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: T lymphocyte cell: A pivotal player in lung cancer.
Wu Y; Yuan M; Wang C; Chen Y; Zhang Y; Zhang J
Front Immunol; 2023; 14():1166352. PubMed ID: 36911679
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells.
Dwivedi A; Karulkar A; Ghosh S; Rafiq A; Purwar R
Front Immunol; 2019; 10():401. PubMed ID: 30906295
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: Alveolar macrophages in lung cancer: opportunities and challenges.
Chang CY; Armstrong D; Corry DB; Kheradmand F
Front Immunol; 2023; 14():1328927. PubMed ID: 38022510
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures.
Wang T; Li T; Li B; Zhao J; Li Z; Sun M; Li Y; Zhao Y; Zhao S; He W; Guo X; Ge R; Wang L; Ding D; Liu S; Min S; Zhang X
Front Immunol; 2023; 14():1134847. PubMed ID: 36742333
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Development of a phagocytosis- dependent gene signature to predict prognosis and response to checkpoint inhibition in clear-cell renal cell carcinoma.
Li K; Li Y; Lyu Y; Tan L; Zheng X; Jiang H; Wen H; Feng C
Front Immunol; 2023; 14():1140764. PubMed ID: 36742313
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma.
Zhang S; Xiao X; Wang Y; Song T; Li C; Bao H; Liu Q; Sun G; Sun X; Su T; Fu T; Wang Y; Liang P
Front Genet; 2022; 13():961153. PubMed ID: 36061198
[TBL] [Abstract][Full Text] [Related]
20. Erratum: New insights into the role of macrophages in cancer immunotherapy.
Frontiers Production Office
Front Immunol; 2024; 15():1427337. PubMed ID: 38817610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
